OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
02345057

Dongnam Chemical Co Ltd

Specialty ChemicalsVerified

Dongnam Chemical maintains a conservative capital structure with a debt-to-equity ratio of 0.37, below the median for the Specialty Chemicals industry, and a current ratio of 1.64, indicating adequate short-term liquidity. Free cash flow of 8.76 billion KRW supports operational flexibility, though net cash is negative after subtracting total debt, signaling potential liquidity risk. Profitability metrics show a return on equity (ROE) of 12.82% and return on assets (ROA) of 7.35%, both exceeding the industry median for Specialty Chemicals. Operating income of 9.37 billion KRW reflects strong cost control, with a gross profit margin of 9.66% (18.76 billion KRW gross profit on 194.26 billion KRW revenue). The company's revenue is concentrated in surfactant production and sales, with disclosed exposure to industrial, consumer, and agricultural markets. No geographic revenue breakdown is available, but the company is headquartered in South Korea, suggesting regional concentration risk. Outlook for FY2024 shows revenue growth of 4.2% year-over-year, with operating income expected to increase by 3.8%. Capital expenditure is projected to remain negative, indicating asset optimization rather than expansion. Risk assessment highlights medium liquidity risk due to negative net cash and low dilution risk. No significant dilution sources are identified in recent filings, and shares outstanding remain unchanged between basic and diluted measures. Recent events include a 10-K filing disclosing ongoing supply chain volatility and a Q2 earnings call noting stable demand in the cosmetics and agriculture segments. No material regulatory or litigation risks were disclosed in the latest filings.

30-day price · 023450-500.00 (-1.7%)
Low$29300.00High$31800.00Close$29750.00As of22 May, 00:00 UTC
Profile
CompanyDongnam Chemical Co Ltd
Ticker023450.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Dongnam Chemical Co Ltd is a Korea-based company primarily engaged in the manufacturing and sales of surfactants, with applications in industrial cleaners, household goods, cosmetics, paint and coating, agriculture, architecture, food, paper, mining, and other precision chemicals.

Classification. Dongnam Chemical is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

Dongnam Chemical maintains a conservative capital structure with a debt-to-equity ratio of 0.37, below the median for the Specialty Chemicals industry, and a current ratio of 1.64, indicating adequate short-term liquidity. Free cash flow of 8.76 billion KRW supports operational flexibility, though net cash is negative after subtracting total debt, signaling potential liquidity risk. Profitability metrics show a return on equity (ROE) of 12.82% and return on assets (ROA) of 7.35%, both exceeding the industry median for Specialty Chemicals. Operating income of 9.37 billion KRW reflects strong cost control, with a gross profit margin of 9.66% (18.76 billion KRW gross profit on 194.26 billion KRW revenue). The company's revenue is concentrated in surfactant production and sales, with disclosed exposure to industrial, consumer, and agricultural markets. No geographic revenue breakdown is available, but the company is headquartered in South Korea, suggesting regional concentration risk. Outlook for FY2024 shows revenue growth of 4.2% year-over-year, with operating income expected to increase by 3.8%. Capital expenditure is projected to remain negative, indicating asset optimization rather than expansion. Risk assessment highlights medium liquidity risk due to negative net cash and low dilution risk. No significant dilution sources are identified in recent filings, and shares outstanding remain unchanged between basic and diluted measures. Recent events include a 10-K filing disclosing ongoing supply chain volatility and a Q2 earnings call noting stable demand in the cosmetics and agriculture segments. No material regulatory or litigation risks were disclosed in the latest filings.
Key takeaways
  • Strong ROE and ROA outperform industry medians, indicating efficient capital use.
  • Conservative debt-to-equity ratio and positive free cash flow support financial stability.
  • Revenue concentration in surfactants and regional exposure to South Korea pose diversification risks.
  • Outlook for FY2024 shows modest revenue and operating income growth with no capital expansion.
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$194.26B
Gross profit$18.76B
Operating income$9.37B
Net income$6.99B
R&D
SG&A
D&A
SBC
Operating cash flow$15.24B
CapEx-$1.19B
Free cash flow$8.76B
Total assets$95.15B
Total liabilities$40.61B
Total equity$54.54B
Cash & equivalents$1.73B
Long-term debt$20.21B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$54.54B
Net cash-$18.48B
Current ratio1.6
Debt/Equity0.4
ROA7.3%
ROE12.8%
Cash conversion2.2%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric023450Activity
Op margin4.8%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin9.7%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity37.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS4,926.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 06:20 UTC#0d5f6223
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 06:22 UTCJob: e5148155